Fast. Accurate. Trusted.
We help laboratories focus on what matters most to patients – correct and fast diagnosis every time. Our genetic test kits with integrated software set new standards in DNA diagnostic testing.
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Cystic fibrosis
Complete sequencing of the CFTR gene to detect all mutations. Learn more
Hematology
Tests to evaluate multiple blood conditions and guide personalized treatment and family planning. Learn more
Reproductive health
Rapid diagnosis of prenatal aneuploidies and male infertility. Learn more
Oncology
Targeted cancer gene sequencing to identify clinically significant variants. Learn more
Cardiovascular diseases
Fast diagnosis and cascade screening for monogenic and polygenic familial hypercholesterolemia. Learn more
“Early treatment made possible by more sensitive diagnostic methods is expected to improve patient survival and significantly reduce the costs for management of transplant patients.”
Dan Hauzenberger, MD., Ph.D., Karolinska University Hospital, Stockholm, Sweden
Insight and inspiration
News | Feb 29, 2024
Devyser announces study publication demonstrating dd-cfDNA detection in dual donor kidney transplant patientNews | Feb 20, 2024
Devyser Diagnostics AB publishes year-end report for January to December 2023News | Feb 06, 2024
Devyser strengthens its management teamLatest from the Devyser blog
View allDevyser publishes annual report for 2023
Devyser´s annual report 2023 has today been published on the company´s website. The report is...
Read more
Devyser CFTR 68 provides NHS Scotland with trustworthy, rapid results
We spoke with Dr. Andrew Purvis, Clinical Scientist for West of Scotland Centre for Genomic...
Read more
Devyser achieves breakthrough in the US with cystic fibrosis NGS test
Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
Read more